The effect of an opiate antagonist on the hormonal changes induced by hexarelin

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Clinical Endocrinology

• Publication date

  1995-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1365-2265.1995.tb02045.xPMID 7586608
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: evidence that GHRP-6 main action is exerted at the hypothalamic level.

  1995cited by this paper
• Growth hormone releasing activity by intranasal administration of a synthetic hexapeptide (hexarelin)

  1994cited by this paper
• Intranasal Administration

  1994cited by this paper
• Growth hormone-releasing activity of hexarelin in humans

  1994cited by this paper
• Growth hormone response in man to L-692,429, a novel nonpeptide mimic of growth hormone-releasing peptide-6.

  1993cited by this paper
• Stimulation of growth hormone release from rat primary pituitary cells by L-692,429, a novel non-peptidyl GH secretagogue.

  1993cited by this paper
• Effect of Intravenous Administration of Growth Hormone-Releasing Peptide on Plasma Growth Hormone in Patients with Short Stature

  1993cited by this paper
• GH Releasing Peptides - Structure and Kinetics

  1993cited by this paper
• Growth hormone-releasing activity of growth hormone-releasing peptide-1 (a synthetic heptapeptide) in children and adolescents.

  1993cited by this paper
• Pituitary adenylate cyclase activating polypeptide, growth hormone (GH)-releasing peptide and GH-releasing hormone stimulate GH release through distinct pituitary receptors.

  1992cited by this paper
• The growth hormone-releasing activity of a synthetic hexapeptide in normal men and short statured children after oral administration.

  1992cited by this paper
• Desensitization studies using perifused rat pituitary cells show that growth hormone-releasing hormone and His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 stimulate growth hormone release through distinct receptor sites.

  1991cited by this paper
• Growth hormone (GH) responses to the hexapeptide GH-releasing peptide and GH-releasing hormone (GHRH) in the cynomolgus macaque: evidence for non-GHRH-mediated responses.

  1991cited by this paper
• Intranasal administration of His-D-Trp-Ala-Trp-D-Phe-LysNH2 (growth hormone releasing peptide) increased plasma growth hormone and insulin-like growth factor-I levels in normal men.

  1991cited by this paper
• On the actions of the growth hormone-releasing hexapeptide, GHRP.

  1991cited by this paper
• Opioid Regulation of Pituitary Function

  1991cited by this paper
• Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone.

  1990influential reference
• A non-opioid pattern characterizes inhibition of growth hormone releasing peptide binding by dynorphin-related peptides.

  1990cited by this paper
• The synergistic effects of His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 on growth hormone (GH)-releasing factor-stimulated GH release and intracellular adenosine 3',5'-monophosphate accumulation in rat primary pituitary cell culture.

  1989cited by this paper
• Effect of a new synthetic hexapeptide to selectively stimulate growth hormone release in healthy human subjects.

  1989cited by this paper
• Measurement of circulating corticotrophin-releasing factor in man.

  1987cited by this paper
• Effects of naloxone on hypothalamo-pituitary-adrenocortical activity in the rat.

  1986cited by this paper
• Different opioid mechanisms are involved in the modulation of ACTH and gonadotrophin release in man.

  1986cited by this paper
• On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone.

  1984cited by this paper
• The effects of growth hormone (GH)-releasing peptides on GH secretion in perifused pituitary cells of adult male rats.

  1984cited by this paper
• Conformational energy studies and in vitro and in vivo activity data on growth hormone-releasing peptides.

  1984cited by this paper
• OPIATES CONTROL ACTH THROUGH A NORADRENERGIC MECHANISM

  1982cited by this paper
• STUDIES OF THE OPIATE CONTROL OF PROLACTIN, GH AND TSH

  1981cited by this paper
• THE RELATIONSHIP BETWEEN CIRCADIAN VARIATIONS IN CIRCULATING THYROTROPHIN, THYROID HORMONES AND PROLACTIN

  1978cited by this paper
• Hormonal and metabolic responses to an enkephalin analogue in normal man.

  1978cited by this paper

• Ghrelin gene products, receptors, and GOAT enzyme: biological and pathophysiological insight.

  2013cites this paper
• Effects of the novel GH secretogogue, hexarelin on GH secretion and phosphatidylinositol hydrolysis by human pituitary somatotrophinomas in cell culture

  2008cites this paper
• From endorphins to ghrelin and back

  2007cites this paper
• Adrenocorticotropin/Cortisol and Arginine-Vasopressin Secretory Patterns in Response to Ghrelin in Normal Men

  2005cites this paper
• Ghrelin Inhibits Prolactin Secretion in Prepubertal Rats

  2004cites this paper
• Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin.

  2004cites this paper
• Growth Hormone, Leptin and Ghrelin

  2004cites this paper
• Non-Growth Hormone Endocrine Actions of Ghrelin

  2004cites this paper
• Ghrelin--a hormone with multiple functions.

  2004cites this paper
• GH and cortisol rebound rise during and following a somatostatin infusion: studies in dogs with the use of a GH-releasing peptide.

  2002cites this paper
• Prolactin-releasing activity of GHRP-5 (Momany peptide) on lactotrophs in vivo and in vitro.

  2002cites this paper
• Biologic activities of growth hormone secretagogues in humans

  2001cites this paper
• Growth hormone-releasing hormone and growth hormone secretagogue-receptor ligands

  2001cites this paper
• Growth hormone-releasing hormone and growth hormone secretagogue-receptor ligands: focus on reproductive system.

  2001cites this paper
• Interaction between glucagon and hexarelin, a peptidyl GH secretagogue, on somatotroph and corticotroph secretion in humans.

  2000cites this paper
• The influence of sex and gonadectomy on the growth hormone and corticosterone response to hexarelin in the rat.

  2000cites this paper
• GH Secretagogues in Aging

  2000influential citation
• GHRP historical perspective

  2000cites this paper
• The Effect of Growth Hormone Secretagogues and Neuropeptide Y on Hypothalamic Hormone Release from Acute Rat Hypothalamic Explants

  1999cites this paper
• Effects of Growth Hormone‐Releasing Peptide‐6 on the Nocturnal Secretion of GH, ACTH and Cortisol and on the Sleep EEG in Man: Role of Routes of Administration

  1999cites this paper
• Corticotropin-Releasing Effect of Hexarelin, a Peptidyl GH Secretagogue, in Normal Subjects Pretreated with Metyrapone or RU-486, a Glucocorticoid Receptor Antagonist, and in Patients with Addison’s Disease

  1999cites this paper
• Endocrine and Non-Endocrine Activities of Growth Hormone Secretagogues in Humans

  1999cites this paper
• The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin.

  1999cites this paper
• Effects of Alprazolam, a Benzodiazepine, on the ACTH-, GH- and PRL-Releasing Activity of Hexarelin, a Synthetic Peptidyl GH Secretagogue (GHS), in Patients with Simple Obesity and in Patients with Cushing's Disease

  1999cites this paper
• Chapter 7 – The Effects of GH-Secretagogues on Human Pituitary Cells in Culture and on Rat Hypothalamic Tissue

  1999cites this paper
• Chapter 12 – Hormonal Activities of Growth Hormone Secretagogues (GHS) across Human Lifespan

  1999cites this paper
• Hexarelin as a test of pituitary reserve in patients with pituitary disease

  1999cites this paper
• Effects of the combined administration of hexarelin, a synthetic peptidyl GH secretagogue, and hCRH on ACTH, cortisol and GH secretion in patients with Cushing’s disease

  1999cites this paper
• The effect of chronic hexarelin administration on the pituitary–adrenal axis and prolactin

  1999influential citation
• The effects of dose, nutrition, and age on hexarelin-induced anterior pituitary hormone secretion in adult patients on maintenance hemodialysis.

  1999cites this paper
• Endocrine Responses to GH Secretagogues in Relation to Sex and Age in Humans

  1999cites this paper
• Tyr-Ala-Hexarelin, a synthetic octapeptide, possesses the same endocrine activities of hexarelin and GHRP-2 in humans

  1999cites this paper
• Growth hormone secretagogues: recent advances and applications.

  1999cites this paper
• Growth Hormone, Growth Hormone Releasing Peptides

  1998cites this paper
• Influence of galanin and serotonin on the endocrine response to Hexarelin, a synthetic peptidyl GH-secretagogue, in normal women

  1998cites this paper
• Growth hormone secretagogues: mechanism of action and use in aging.

  1998cites this paper
• Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human.

  1998cites this paper
• Opioid-Receptor Blockade Blunts Growth Hormone (GH) Secretion Induced by GH-Releasing Hormone in the Human Male

  1998cites this paper
• Effects of Dexamethasone and Alprazolam, a Benzodiazepine, on the Stimulatory Effect of Hexarelin, a Synthetic GHRP, on ACTH, Cortisol and GH Secretion in Humans

  1998cites this paper
• Orally active growth hormone secretagogues: state of the art and clinical perspectives.

  1998cites this paper
• Adrenocorticotropin and cortisol hyperresponsiveness to hexarelin in patients with Cushing's disease bearing a pituitary microadenoma, but not in those with macroadenoma.

  1998cites this paper
• Growth hormone-releasing peptides and their analogs.

  1998cites this paper
• Growth hormone secretagogues as corticotrophin-releasing factors.

  1998cites this paper
• Growth Hormone‐Releasing Peptides

  1998cites this paper
• Interaction of the growth hormone releasing peptide hexarelin with somatostatin

  1997cites this paper
• Influence of chronic naltrexone treatment on growth hormone secretion in normal subjects.

  1997cites this paper
• Age‐related growth hormone‐releasing activity of growth hormone secretagogues in humans

  1997cites this paper
• Growth hormone-releasing peptides.

  1997cites this paper
• Effects of GHRP-2 and hexarelin, two synthetic GH-releasing peptides, on GH, prolactin, ACTH and cortisol levels in man. Comparison with the effects of GHRH, TRH and hCRH.

  1997cites this paper
• Hexarelin, a synthetic growth-hormone releasing peptide, shows no interaction with corticotropin-releasing hormone and vasopressin on adrenocorticotropin and cortisol secretion in humans.

  1997cites this paper
• Effects of histaminergic antagonists on the GH-releasing activity of GHRH or hexarelin, a synthetic hexapeptide, in man

  1997cites this paper
• The GH, prolactin, ACTH and cortisol responses to Hexarelin, a synthetic hexapeptide, undergo different age-related variations.

  1997influential citation
• Absence of desensitization by hexarelin to subsequent GH releasing hormone‐mediated GH secretion in patients with anorexia nervosa

  1997cites this paper
• The sequential administration of growth hormone‐releasing hormone followed 120 minutes later by hexarelin, as an effective test to assess the pituitary GH reserve in man

  1996cites this paper
• Hexarelin-induced growth hormone, cortisol, and prolactin release: a dose-response study.

  1996cites this paper
• Diagnosis of growth hormone deficiency in adults.

  1996cites this paper